The S&P/ASX 200 Index (ASX: XJO) has just closed November at 8,436.2 points.
This means the benchmark index is up 11.1% since the start of the year.
While this is an impressive return, some ASX 200 shares have managed to significantly outperform the market. Here are the 10 best ASX 200 shares of 2024 so far:
The Zip Co share price is the clear market leader this year with a stunning 439% gain. The buy now pay later's impressive shift to profitable growth has been a key driver of this rampant rise.
The Life360 share price has been the next best performer so far in 2024 with a gain of 235%. This location technology company's very strong performance and listing on the Nasdaq has helped drive its shares higher.
The Sigma Healthcare share price has risen 188% since the start of the year. Excitement relating to its proposed merger with Chemist Warehouse is behind this rise.
The Pro Medicus share price isn't far behind with a 163% gain in 2024. This health imaging technology company has winning huge contracts again this year thanks to strong demand for its industry leading Visage platform.
The Telix Pharmaceuticals share price has raced 145% higher this year. This radiopharmaceuticals company has reported strong Illuccix sales growth again and made progress with regulatory approvals.
The Pinnacle Investment Management share price is up 133% year to date. A strong performance in FY 2024 and a recent acquisition have gone down well with investors.
The Hub24 share price has charged 109% higher year to date. This investment platform provider wowed the market with further strong funds under administration growth.
The HMC Capital share price is up 100% since the start of the year. After delivering a strong result in FY 2024, HMC Capital is on track to deliver an even stronger result in FY 2025. This is thanks partly to its data centre venture.
The Netwealth Group share price is also up 100% since the start of the year. Like Hub24, this has been driven by impressive funds under administration growth.
The Judo Capital share price has climbed 99.5% year to date. The small business lender caught the eye with its strong performance in FY 2024 and benefitted from a banking sector rally.
The post These are the 10 best ASX 200 shares of 2024 so far appeared first on The Motley Fool Australia.
Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended HMC Capital, Hub24, Life360, Netwealth Group, Pinnacle Investment Management Group, Telix Pharmaceuticals, and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Netwealth Group and Pinnacle Investment Management Group. The Motley Fool Australia has recommended HMC Capital, Hub24, Pro Medicus, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2024